cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Ocugen Inc
131 own
87 watching
Current Price
$0
$-0.03
(-2.82%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
268.69M
52-Week High
52-Week High
4.53
52-Week Low
52-Week Low
1.09
Average Volume
Average Volume
1.1M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization268.69M
icon52-Week High4.53
icon52-Week Low1.09
iconAverage Volume1.1M
iconDividend Yield--
iconP/E Ratio--
What does the Ocugen Inc do?
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company s pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing; and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company is headquartered in Malvern, Pennsylvania.
Read More
How much money does Ocugen Inc make?
News & Events about Ocugen Inc.
Globe Newswire
7days ago
MALVERN, Pa., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced the appointment of Quan A. Vu as Chief Business Officer, ...
Globe Newswire
8days ago
MALVERN, Pa., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that Dr. Shankar Musunuri, Chairman, Chief Executive ...
PR Newswire
30days ago
Thinking about buying stock in Duck Creek Technologies, CureVac, Day One Biopharmaceuticals, Bed Bath & Beyond, or Ocugen? Thinking about buying stock in Duck Creek Technologies, CureVac, Day One Biopharmaceuticals, Bed Bath & Beyond, or Ocugen? PR Newswire NEW YORK, Jan. 9, 2023...
Globe Newswire
1month ago
Important next step for Ocugens regenerative cell therapy in orthopedics since announcing pipeline expansion in May 2022MALVERN, Pa., Dec. 16, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing...
Globe Newswire
1month ago
MALVERN, Pa., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that Dr. Shankar Musunuri, Chairman, Chief Executive ...
Frequently Asked Questions
Frequently Asked Questions
What is Ocugen Inc share price today?
plus_minus_icon
Can Indians buy Ocugen Inc shares?
plus_minus_icon
How can I buy Ocugen Inc shares from India?
plus_minus_icon
Can Fractional shares of Ocugen Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Ocugen Inc stocks?
plus_minus_icon
What is today’s traded volume of Ocugen Inc?
plus_minus_icon
What is today’s market capitalisation of Ocugen Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Ocugen Inc?
plus_minus_icon
What percentage is Ocugen Inc down from its 52-Week High?
plus_minus_icon
What percentage is Ocugen Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$-0.03
(-2.82%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
VERRICA PHARMACEUTICALS INC
VERRICA PHARMACEUTICALS INC
$5.99
$0.27 (4.72 %)
KINNATE BIOPHARMA INC
KINNATE BIOPHARMA INC
$7.50
$-0.21 (-2.66 %)
Annexon Inc
Annexon Inc
$6.84
$-0.26 (-3.66 %)
Nkarta Inc
Nkarta Inc
$5.57
$-0.07 (-1.33 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
VERRICA PHARMACEUTICALS INC
VERRICA PHARMACEUTICALS INC
$5.99
$0.27 (4.72 %)
KINNATE BIOPHARMA INC
KINNATE BIOPHARMA INC
$7.50
$-0.21 (-2.66 %)
Annexon Inc
Annexon Inc
$6.84
$-0.26 (-3.66 %)
Nkarta Inc
Nkarta Inc
$5.57
$-0.07 (-1.33 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00